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New CDC Zika Virus Guidance: Implications for Iowa Healthcare 
Providers 
 
Interpreting Results 
Because of the decreasing prevalence of Zika virus in many areas of the world, CDC is alerting healthcare and 
public health partners of a likely increase in the rate of false-positive results in the initial testing completed at 
reference laboratories and state health departments (IgM testing results). In light of this development, it is very 
important that all samples testing presumptive positive and equivocal be sent to CDC for confirmatory testing 
(be aware that it may take up to a month to get confirmatory results back from CDC).  
• All presumptive positive and equivocal samples identified at the State Hygienic Laboratory have and 
will continue to be sent to the CDC for confirmatory testing.  
• If providers chose to submit samples to reference laboratories for Zika virus testing and receive 
presumptive positive or equivocal results, please contact IDPH by calling 800-362-2736 to ensure 
that the specimens are promptly forwarded to CDC for confirmatory testing.  
 
In addition, the length of time in which IgM antibodies persist at detectable levels in Zika infected persons is 
highly variable.  In some persons, antibodies are not detectable beyond 12 weeks post infection, but in others 
antibody persist well beyond that length of time.  
• Therefore, for in persons who seek care >12 weeks after symptom onset or exposure (if 
asymptomatic), a negative result does not rule out an infection because IgM antibody levels decline 
over time (and PCR will not detect virus that long after acute infection). 
• Conversely, Zika virus IgM antibodies can persist beyond 12 weeks post infection in some infected 
persons.  Therefore, in persons who previously resided in or who have multiple dates of travel to 
Zika areas, results cannot always distinguish when the infection occurred (this has implications for 
pregnant women who previously resided in or had multiple dates of travel to Zika areas during and 
prior to their pregnancy). 
  
Testing Recommendations 
1. CDC continues to recommend Zika virus testing for all symptomatic persons (including persons who 
are pregnant and not pregnant) with possible Zika virus exposure through travel or sex.   
2. CDC is no longer routinely recommending Zika virus testing for asymptomatic pregnant women with 
possible Zika virus exposure through travel or sex.  Instead, CDC is recommending that patients 
and their healthcare providers work together to make decisions about testing and care plans based 
on patient preferences and val¬ues, clinical judgment, and a balanced assessment of risks and 
expected outcomes.  
The State Hygienic Laboratory will test all symptomatic patients and asymptomatic pregnant women (if 
the patient and provider make the decision to test) with a history of Zika virus exposure.  Iowa 
Healthcare Providers wishing to test their patients for Zika virus infection should continue to contact 
IDPH at 800-362-2736 to initiate sample submission. 
 
Additional CDC Recommendations for Pregnant Women 
• All pregnant women in the United States should be screened for possible Zika virus exposure before 
and during the current pregnancy, at every prenatal care visit.  
• Pregnant women should not travel to any area with risk for Zika virus transmission 
(https://wwwnc.cdc.gov/travel/page/zika-travel-information).  
• Pregnant women whose sexual partners have traveled to or live in an area with Zika virus transmission 
should use condoms or abstain from sex for the duration of the pregnancy. 
 
The updated guidance, including guidance for pregnant women with ongoing exposure (repeat travel to areas 
where Zika virus is transmitted) can be accessed 
at: https://www.cdc.gov/mmwr/volumes/66/wr/mm6629e1.htm?s_cid=mm6629e1_w  
 
Infant Monitoring Recommendations 
Infants born to mothers with possible Zika virus exposure during pregnancy who did not receive testing, who 
tested negative more than 12 weeks after exposure/symptom onset, or had additional exposures after testing 
occurred should receive a comprehensive physical examination, including standardized measurement of head 
circumference and newborn hearing screen, as part of routine pediatric care. Healthcare providers should also 
consider performing a head ultrasound, conducting an ophthalmologic assessment, and testing the infant for 
Zika virus infection. 
 
For additional guidance on infant monitoring visit:  
https://www.cdc.gov/mmwr/volumes/65/wr/mm6533e2.htm?s_cid=mm6533e2_w 
 
Iowa Healthcare Providers wishing to test their patients for Zika virus infection should continue to 
contact IDPH at 800-362-2736 to initiate sample submission. 
 
 
